NCT00124735View on ClinicalTrials.gov

A Study to Determine the Dose Requirements of Rocuronium Bromide (Zemuron®) in Pediatric and Adolescent Subjects (21048)(COMPLETED)(P05797)

PHASE3CompletedINTERVENTIONAL

Enrollment

149

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

August 31, 2007

Study Completion Date

September 30, 2007

Conditions

Anesthesia

Interventions

DRUG

Rocuronium bolus maintenance

Subjects received a bolus dose of rocuronium for intubation followed by bolus doses for maintenance of muscle relaxation

DRUG

rocuronium continuous infusion maintenance

Subjects received a bolus dose of rocuronium for intubation followed by continuous infusion of rocuronium for maintenance of muscle relaxation

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00124735 - A Study to Determine the Dose Requirements of Rocuronium Bromide (Zemuron®) in Pediatric and Adolescent Subjects (21048)(COMPLETED)(P05797) | Biotech Hunter | Biotech Hunter